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Abstract
Background: Multimorbidity is becoming increasingly prevalent and presents challenges for healthcare providers
and systems. Studies examining the relationship between multimorbidity and quality of care report mixed findings.
The purpose of this study was to investigate quality of care for people with multimorbidity in the publicly funded
healthcare system in Denmark.
Methods: To investigate the quality of care for people with multimorbidity different groups of clinicians from the
hospital, general practice and the municipality reviewed records from 23 persons with multimorbidity and discussed
them in three focus groups. Before each focus group, clinicians were asked to review patients’ medical records
and assess their care by responding to a questionnaire. Medical records from 2013 from hospitals, general practice, and
health centers in the local municipality were collected and linked for the 23 patients. Further, two clinical pharmacologists
reviewed the appropriateness of medications listed in patient records.
Results: The review of the patients’ records conducted by three groups of clinicians revealed that around half of
the patients received adequate care for the single condition which prompted the episode of care such as a
hospitalization, a visit to an outpatient clinic or the general practitioner. Further, the care provided to approximately two-
thirds of the patients did not take comorbidities into account and insufficiently addressed more diffuse symptoms or
problems. The review of the medication lists revealed that the majority of the medication lists contained inappropriate
medications and that there were incongruity in medication listed in the primary and secondary care sector.
Several barriers for providing high quality care were identified. These included relative short consultation times in
general practice and outpatient clinics, lack of care coordinators, and lack of shared IT-system proving an overview of
the treatment.
Conclusions: Our findings reveal quality of care deficiencies for people with multimorbidity. Suggestions for care
improvement for people with multimorbidity includes formally assigned responsibility for care coordination, a change
in the financial incentive structure towards a system rewarding high quality care and care focusing on prevention of
disease exacerbation, as well as implementing shared medical record systems.
Keywords: Comorbidity, Delivery of health care – organization and administration, Health care quality, access, and
evaluation, Disease management, Medication errors, Qualitative research
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Background
Multimorbidity is the coexistence of two or more
chronic conditions. Prevalence estimates vary widely, but
as many as 50 million Europeans may live with multi-
morbidity [1]. What is certain is that the prevalence of
multimorbidity is rising and increases with age and so-
cioeconomic deprivation [2–4]. In the Capital Region of
Denmark 21% of the adult population have two or more
chronic conditions [5]. Multimorbidity affects quality of
life, ability to work, disability, mortality, and processes of
care and has a significant impact on healthcare
utilization and costs [6].
The relationship between multimorbidity and quality
of care has been examined in recent years. Quality of
care for patients with multimorbidity is most appropri-
ately measured by processes, rather than outcomes [7].
Some studies have found that higher comorbidity bur-
den is associated with better quality of care [8, 9], but
this relationship has not been consistently demonstrated
[10]. Quality of care appears to vary substantially by how
time-consuming care processes are, rather than by the
complexity or number of conditions [11]. Several studies
have documented quality of care deficiencies when pa-
tients have discordant or unrelated comorbidities [12].
Each condition with unrelated pathophysiology or re-
quiring different care includes a risk of suboptimal man-
agement that include missed diagnoses, inadequate
treatment and access, and communication barriers [13].
In addition, treatment for multimorbidity often requires
multiple condition-specific medications, resulting in
polypharmacy and attendant risks [12–15].
Knowledge about how people with multimorbidity are
treated and cared for in the Nordic countries with pub-
licly financed health care systems is limited. The aim of
the study was to investigate the quality of care for people
with multimorbidity in the Danish Healthcare System.
Methods
In order to investigate the quality of care for people with
multimorbidity different groups of clinicians reviewed
records from a selected group of patients with multi-
morbidity. The group of clinicians discussed the quality
of care in three focus group interviews. Further, the ap-
propriateness of the medications of the patients was
reviewed by clinical pharmacologists using the Screening
Tool to Alert doctors to Right Treatment and Screening
Tool of Older Persons’ potentially inappropriate Pre-
scriptions (START-STOPP criteria) and the Medication
Appropriateness Index (MAI) [16–18].
Setting
The Danish Healthcare System (DHS) is a publicly
funded healthcare system belonging to the same family
of healthcare systems as those of the other Scandinavian
countries and the United Kingdom [19, 20]. All regis-
tered Danish residents are automatically entitled to
health care, which is largely free at the point of use [21].
In the DHS, people with chronic conditions are primar-
ily treated by general practitioners (GPs). The GPs act as
gatekeepers with regard to referring patients to hospital
and specialist treatment. This means that patients usu-
ally start the process of seeking health care by consulting
their GP, whose job is to ensure that the patient is of-
fered the necessary treatment but also that the patient is
not treated at a higher specialization level than neces-
sary. Patients can also be referred for rehabilitation by
the GPs or from specialists at the hospital. Rehabilitation
can take place at the prevention centers run by munici-
palities or at rehabilitation programs at hospitals. GPs
and specialists (including private specialists and special-
ists working at the hospitals) can prescribe medication.
The prescribed medication can subsequently be bought
at pharmacies [20].
Design
We used a case series with planned chart review. We ob-
tained medical records from the primary care sector, the
hospital sector, and the municipality of Copenhagen for
individuals with multimorbidity. We randomly selected
patients from the Bispebjerg University Hospital (BUH)
administrative system who had: 1) two or more of the
most prevalent chronic diseases among the adult po-
pulation in the Danish Capital Region—cardiovascular
disease (ICD-10 code I21.0-I21.9), unstable angina
(I20.0), stable angina (I25.1), heart failure (I50), type 1
diabetes (E10.0-E10.9), type 2 diabetes (E11.0-E11.9),
chronic obstructive pulmonary disease (COPD, J44.x),
and depression (DF33.x) [22]; and 2) at least one out-
patient or inpatient encounter at BUH between January
1 and December 31, 2013.
Population
From the group of randomly selected patients we se-
lected a group of 133 individuals that matched the age
and gender distribution of the population with multi-
morbidity [5]. Each individual received a letter with in-
formation about the study and a consent form allowing
us to obtain and review their records from hospitals in
the Capital Region, their general practitioner (GP), and
the Municipality of Copenhagen. Approval was obtained
from the Danish Data Protection Agency.
Of the 133 selected individuals, 80 (60%) returned a
signed consent form. We reviewed their records to verify
that each individual had two or more of the qualifying
conditions. We excluded 43 patients as it appeared from
their patient records that they did not have one or more
of the chronic index conditions. Thirty-seven patients
were included in the full record review process. Twenty-
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five (68%) of these patients had received services from
the municipality. We contacted the GPs of all 37 pa-
tients to obtain complete medical records; three GPs
did not provide access to their patients’ medical records
and we were unable to reach 10 GPs. Consequently, 24
medical records with information from hospitals, gen-
eral practice, and the municipality were available. One
patient’s medical record was used for pilot testing the
review process, leaving 23 records for review in the
study. The characteristics of participating patients are
listed in Table 1.
Chart review and focus groups
In total three focus group meetings were held in order to
conduct the chart reviews and discuss the care processes.
At the first two focus group meeting eight patient records
were reviewed. Seven patient records were reviewed at the
third focus group meeting. Each focus group meeting
were attended by a group of six consisting of one general
practitioner, two consultant physicians, a nurse from the
prevention center at the Municipality of Copenhagen, and
a nurse specialist from home care nursing at the Munici-
pality of Copenhagen. In total three consultant physicians
(consultants in endocrinology, cardiology, and pulmonol-
ogy) participated in two meetings each, at which the re-
cords of all individuals with diseases within their specialty
were reviewed. Three different GPs participated, one at
each of the three focus group meetings. Two nurse spe-
cialists from home care nursing at the Municipality of
Copenhagen participated, one of them in one of the meet-
ings, and the other in two of the meetings. Further, one
nurse from the prevention center at the Municipality of
Copenhagen participated in all three meetings.
Before each meeting, clinicians were asked to review
patients’ medical records and assess the quality of care
by responding to a questionnaire (Table 2). Clinicians
also received general information about each patient that
included age, gender, civil status, diagnoses, lifestyle,
places of treatment, patient involvement, information
transfer between providers, and the use of telehealth and a
graphical overview of each patient’s contact with the
healthcare system in 2013.Quality of care was assessed
based on the clinicians’ group discussions according to
their responses to the questionnaire (Table 2). The group
discussions focused on each patient’s care and highlighted
quality issues and suggestions about how to improve care
quality. The responses from the clinicians were based on
clinical guidelines, disease management programs and
clinical standards for the relevant chronic conditions. The
discussions were facilitated by two of the researchers
(M.L.S. and D.H.) and were audio taped and transcribed.
All transcribed discussions were coded and categorized
inductively using qualitative content analysis [23–25], pri-
marily inspired by Graneheim and Lundman [23] and sup-
ported by NVivo 10 software. We focused on the manifest
content of data [23–25]. We first read the transcribed in-
terviews in their entirety to obtain a sense of the whole
[24, 25]. The conclusions of the discussions were then
summarized by the two researchers (M.L.S. and D.H.) and
presented for the group of clinicians in order to make sure
that the participants agreed with the conclusions.
Medication review
Two clinical pharmacologists (physicians with a specialty
in clinical pharmacology) also reviewed the 23 patient
records. Both clinical pharmacologists reviewed all the
23 cases - one as primary data extractor and one as sec-
ondary. Possible differences in interpretation, of which
there were few, were solved by discussion until unison.
Information about prescribed medications was obtained
from the patient records and the medication lists of the
patients. Prescribed medications were assessed using the
validated Pharmaceutical Care Network Europe (PCNE)
drug-related problems classification. PCNE defines a
drug-related problem as an event or circumstance that
requires medical treatment or unequivocally hinders a
desired state of health [20]. Medication appropriateness
was assessed using the Screening Tool to Alert doctors
to Right Treatment and Screening Tool of Older
Persons’ potentially inappropriate Prescriptions (START-
STOPP criteria) and the Medication Appropriateness
Index (MAI) [16–18]. The START-STOPP criteria com-
prise a list of 114 indications of potentially inappropriate
medication use and clinically significant undertreatment.
The list, based on consensus among 19 experts in geria-
tric pharmacology from 13 European countries, was up-
dated in October 2014 [26]. MAI is a standardized
method to assess whether pharmacotherapy prescribed
for older individuals is appropriate. It comprises an audit
of 10 items including indication, dose, and interactions
with other drugs and diseases.
Table 1 Patient characteristics
Female gender, n (%) 15 (65)
Mean age in years (range) 68.7 (49–88)
Ethnicity, n (%)
Ethnic Dane 19 (83)
Other ethnicity 4 (17)
Living situation, n (%)
Alone 15 (65)
In a nursing home 2 (9)
With a partner or children 6 (26)
Mean number of chronic conditions (range) 4 (2–8)
Mean number of prescribed medications (range) 15 (5–23)
Mean number of bed days (range) 12.7 (0–55)
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Results
In general, reviewing clinicians assessed that approxi-
mately 50% of patients received adequate treatment for
the single condition that prompted an episode of care
such as a hospitalization, a visit to an outpatient clinic
or the general practitioner. However, the care provided
to approximately two-thirds of patients did not take co-
morbidities into account and insufficiently addressed
more diffuse symptoms or problems. Medication lists
contained inappropriate medications, and lists in pri-
mary and secondary care sectors differed.
A specialized approach to care
Reviewing clinicians found that, for approximately two-
thirds of patients, the care did not take comorbidities
into account or address problems such as risk of falls,
dyspnea, pain, cognitive impairment, poor nutrition, and
mental health issues. One of the reviewing nurses said:
“It seems like the problem is that when something is
acute, then the other issues are pushed aside and
therefore it is overlooked. It seems like physical
exercise earlier on could have been relevant for her
due to loss of functional capacity”.
From the discussions of the clinicians based on the re-
cords it appeared that for most of the patients, part of
the treatment was following the clinical guidelines. How-
ever, due to the complexity of the symptom pattern with
several chronic conditions sometimes combined with so-
cial problems, the reviewing clinicians also identified
areas of the medical treatment that was not taken care
off for most of the patients. One specialist said:
“…Looking at the entire patient course, I see that
what is working is the lung treatment – the
management of the COPD works. And the heart
rehabilitation works but the mental issues are
overseen. (…) Also, the hyperthyroidism is overseen.
The GP has data saying that she is hyperthyroid
which is why she gets atrial fibrillation which we
should have managed…”.
Further, in several of the patients’ records the review-
ing clinicians identified that there was confusion related
to diagnoses:
“…Unfortunately her medication (for COPD) has
not been stopped. She doesn’t have COPD. The new
Table 2 Themes and questions in questionnaire assessing care used by reviewing clinicians
Overall theme Specific theme Questions
Health care services
provided
Has the right treatment been offered? - Do you assess that the patient has received the right
professional treatment?
Has the patient been offered the needed amount
of self-management support?
- Do you assess that the patient has received the necessary
self-management support (e.g. support to self-monitoring,
conduct lifestyle changes and medication management)
Has the patient been offered appropriate
rehabilitation?
- Do you assess that the patient has received relevant and
sufficient rehabilitation services?
Does the patient receive treatment in the
appropriate settings?
- Does the patient receive treatment in the appropriate
settings?
Does the patient receive treatment from the
appropriate providers?
- Does the patient receive care from relevant providers?
- Do you assess that the patients have received the necessary
care from specialists?
- Do you assess that the patient has received the necessary
nurse care?
- Do you assess that the patient has received the necessary
care from general practice?
- Do you assess that the patient has received the necessary
home nurse care?
Medical treatment Is medical treatment appropriate? Does the patient receive appropriate treatment?
Does medical treatment take comorbidity into
account?
Does the medical treatment take co-morbidity into account?
Are the prescribed medications relevant taken the full
pathological picture into account?
Are medications missing from treatment? Are there relevant medication missing?
Is there a risk of drug-drug interactions? Is there a risk of drug-drug interaction?
Can some prescribed medications affect
comorbidities?
Can some of the prescribed medications affect the patients’
comorbidities?
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lung function test shows that she is normal, and
then nobody tells her to stop taking her medication.
I feel sorry for her…”.
From the records the reviewing clinicians also identi-
fied that hospital specialists were inattentive to condi-
tions outside their own medical specialty. As one
clinician said:
“Some of our medical specialists are working with
blinders on. They only look at the lungs – as if the
patient had no other organs.”
Preventive care
With regard to the provision of preventive healthcare,
the reviewing clinicians found that appropriate prevent-
ive healthcare was lacking for a large part of the patients;
for example, most patients did not received counseling
related to smoking cessation or nutrition nor assistance
and support related to physical activity and excess alco-
hol use. One of the participating nurses said:
“For dyspnoea, COPD and sleep apnoea he gets
appropriate treatment (…). Then there is smoking
where the treatment is not ideal”.
Within the hospital setting, the reviewing clinicians
described how clinicians’ primary focus on acute care
made it difficult to integrate prevention and rehabilita-
tion into care. One reviewing clinician from the hospital
described prevention as having vanished from the treat-
ment of somatic illnesses:
“When the patients are here (in the hospital), we
don’t think about prevention. I know it’s a quality
measure, and I think that maybe the nurses care
about it, but not the doctors; I don’t think they
care about it.”
In addition, it appears from the clinicians’ review of
the patient records, that patients did not always receive
mandatory yearly or half-yearly check-ups or the recom-
mended flu vaccine.
Inappropriate prescribing patterns
During record review, clinical pharmacologists identified
that the number of prescribed medications for each pa-
tient ranged from 5 to 23. They identified at least one
inappropriate medication, as determined by the MAI
criteria, on 78% of medication lists (Table 3). The pro-
portion of medications for each patient that were in-
appropriate ranged from zero to 33%, with a median of
13%. The most frequent inappropriate medications were
opioids, long-term use of benzodiazepines and of pro-
ton pump inhibitors without indication, and duplica-
tions (e.g., psychoactive drugs, such as antipsychotics
and antidepressants, inappropriately within the same
drug class). The records of patients with prescribed an-
tipsychotics lacked documentation of treatment effect-
iveness and side effects were monitored insufficiently, if
at all. Likewise, the need for continuing treatment was
not assessed sufficiently. Insufficient treatment with
statins and medications for osteoporosis was common.
For 16 (70%) patients, clinical pharmacologists identi-
fied discrepancies between medication lists in the pri-
mary and secondary care sectors; the number of
discrepancies ranged from one to eight. They primarily
related to as-needed (PRN) sleep medications, nonste-
roidal anti-inflammatory drugs, and morphine.
In general, the medication review revealed that the
quality of pharmacotherapy varied substantially between
patients. The records of some patients reflected ad-
equate treatment, while others reflected too many or too
few medications.
Factors affecting the quality of care for people with
multiple chronic conditions
During the focus group discussions the reviewing clini-
cians identified several factors affecting the quality of
care provided to patients with multiple chronic condi-
tions. Relatively short consultation times (10–15 min) in
general practice and at hospital outpatient clinics were
mentioned several times as a barrier to providing com-
prehensive care for people with multiple conditions. A
specialist described this challenge:
“…preparation time prior to seeing the patients is
the key. And there is no preparation time prior to
any of the patients. We need to do it directly. (…)
This means I need to do overtime work the day
before I have outpatient consultations – using my
Table 3 Medication review results
Discrepancy between sectors in medication lists, % 70
Medication Appropriateness Index
Patients with medication lists rated as inappropriate, % 78
Number of inappropriate medications per patient,
median (range)
2 (0–6)
Inappropriate medications as percentage of total
medications per patient, % (range)
13 (0–33)
START-STOPP
Number of START-STOPP points per patient, median
(range)
2 (0–5)
Number of medications per patient with discrepancy
between sectors in medication lists, median (range)
1 (0–8)
Abbreviations: START-STOPP screening tool to alert doctors to right treatment
and screening tool of older persons’ potentially inappropriate prescriptions
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own time to look through the records. I am not
always doing that. (…). Alternatively, I use two
minutes out of the ten minutes to read what I can
from the last two notes, check up the blood tests,
check up on the results from the scanning if the
person has been scanned, and then when the person
enters, I need to update the medication chart, talk
to the patient, if I have time to look at the patient at
all, how is he and everything, and then when the
patient is finished, I need to dictate and close down
– in ten minutes total.”
Also, the specialized mentioned focus of care as a bar-
rier for providing high quality care for people with mul-
timorbidity. A physician stated:
“It is a little bit too complicated. With that I think of
this patient if it is mental or what it is. Somewhere it
is mentioned that he is known with osteoporose, and
then he needs a DEXA scanning (…). If he has
osteoporosis and he walks around with some micro
fractures. Maybe this is actually what is wrong with
him when he comes in (to the hospital) with pain. So
you can say that you should look at him with new
eyes. Who should do that? That is the problem with
the specialties that they operate within their own field
and focus on that.”
Further, the lack of care coordination was mentioned
as a challenge in order to get coordinated high quality
care:
“It seems like the patients express a wish for being
self-sufficient and be able to get around. She wants to
exercise. But it is like nothing is happening. No one
picks it up. Then when the nurse from the prevention
center thinks she has COPD and is referred to the GP,
no one gather the threads and sees whether she gets
in contact with the GP and what the result was”.
Reviewing clinicians also identified the need for infor-
mation technology (IT) tools providing a treatment over-
view and reminders related to patients’ test results to
ensure better and more coordinated management of pa-
tients. Such tools were perceived as potentially alleviating
healthcare professionals’ overfilled schedules. However,
because they were not available health care professionals
relied on patients to convey relevant information. When
this information was unavailable, health care professionals
found it difficult to obtain a treatment overview, and er-
rors resulted. As one reviewing clinician described:
“There are no clear solutions. You just have to
prioritize. We have a lot of different tasks – for
example, we do regular check-ups of COPD and dia-
betes patients, and we do it blindfolded so to speak –
just because it’s in the guidelines. And that’s really
resource-intensive. If we had some tools; for example,
a red light flashing could indicate a patient in need of
something special (…) if we could prioritize our time
differently. Such tools could be created based on our
existing databases, and hereby we could actually iden-
tify patients at risk, for example, by looking at patients
who are often hospitalized”.
Also, the reviewing clinicians noted the difficulty of
obtaining a comprehensive and accurate overview of
patients’ prescribed medications, which could result in
duplicate, contraindicated, or otherwise erroneous pre-
scriptions and medication errors. In relation to this, the
clinicians described that updating and managing medica-
tion lists was time-consuming, converting hospitalized
patients’ medication to the standard hospital formulary
was challenging, and distinguishing between different
but closely related medications could be difficult. They
also pointed out that poor awareness of patients’ comor-
bidities made it harder to assess the need for medication
changes and described trying to assess patients’ medica-
tion problems with inadequate information:
“She has pain and this is why she gets in contact
with the GP. The GP is lost several times because
the medication list is not up-dated. So many of the
consultations are just focused on getting the
medication right. That is a problem and the
patient gets lost in it”.
Additionally, reviewing clinicians described the time-
consuming and complicated process of tapering patients
off sedative medications. Avoiding the inappropriate
continuation of medications required obtaining compre-
hensive information and scheduling several follow-up
visits, both of which were difficult for reviewing clini-
cians to accomplish.
Discussion
The current study examined the quality of care for people
with multimorbidity by reviewing the records of 23
patients for an entire calendar year and using focus group
discussions to elucidate quality issues and important fac-
tors contributing to them. In general, care provided to
people with multimorbidity focused on treatment for a
single disease and did not take into account either comor-
bidities or more general problems such as pain, mental
health issues, dizziness and cognitive impairment. Pre-
ventive care was provided to only a limited degree. Record
review by clinical pharmacologists identified inappropriate
medications in the majority of patients’ medication lists,
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and discrepancies between medication lists in the primary
and secondary care sectors were identified for the majority
of patients.
Reviewing clinicians identified several factors contribu-
ting to inadequate care: time pressure, lack of compre-
hensive information about patients, lack of required
information technology tools, specialization of care, and
neglect of preventive care in the hospital setting. They de-
scribed medication issues as related to a lack of compre-
hensive information about patients and time pressures.
Our results are consistent with those of other studies
reporting quality of care deficiencies when patients have
discordant or unrelated comorbidities [27–31]. Multi-
morbidity that includes both physical and mental health
conditions is associated with a greater risk of quality and
safety issues [32]. Physicians are less likely to address
diffuse symptoms like pain and breathing problems
among patients with poorer health status [33]. Multiple
studies in primary care settings suggest that the quality
of preventive care is not associated with increasing mul-
timorbidity [8, 34, 35]; however, our assessment of pre-
ventive care included secondary care settings and we
were unable to identify comparable studies to which we
could compare our findings.
Record review by clinical pharmacologists identified
that 78% of medication lists had at least one inappropri-
ate drug, according to the MAI criteria. Previous studies
report inappropriate medication rates of 15% to 59% at
the level of patients [36–38]. Because we examined mul-
tiple medication lists for the patients in our study, we
cannot directly compare our findings to these results;
however, we note that the prevalence of inappropriate
medications appears to be relatively high among the pa-
tients we studied. Other studies also found that benzodi-
azepines were a commonly inappropriate medication
among patients with multimorbidity [36].
Factors identified by reviewing clinicians as affecting
the quality of care were similar to those reported in
other studies of care for people with multiple chronic
conditions. For instance, lack of time has been identified
as a barrier to providing care for patients with multimor-
bidity [13, 30, 39]. Longer consultations result in more
preventive health advice, less prescribing, and increased
patient satisfaction [40]. The need in primary care for
care management software integrated into patients’
EHRs has also been previously reported [41], and related
challenges posed by a lack of adequate patient informa-
tion are well known [39]. A pervasive and persistent
need for systematic medication reconciliation exists
across care settings, particularly during transitions be-
tween home and hospital care [42].
Strengths of our study include detailed review of med-
ical records for an entire year by clinicians from munici-
pal, general practice, and hospital care settings and a
medication review conducted by two clinical pharmacol-
ogists. Additionally, the cases were selected based on
evidence about combinations of chronic conditions in
the larger population, ensuring that the selected combi-
nations of diseases were the most prevalent disease clus-
ters. Study limitations include using medical records as a
complete and accurate reflection of care; it is possible
that the records we reviewed did not contain documen-
tation of some aspects of care. Further, the way the med-
ical records were obtained entailed a selection process.
This meant that the most ill persons with multimorbid-
ity highly probable were not included in the study popu-
lation as they had died before the data collection started
or were too sick to return the consent form. Addition-
ally, the process implied that medical records of patients
where we were not able to get in contact with their GP
or where the GP refused to share the medical records
were not included in the review. This could mean that
the medical records we reviewed are not representative
for the entire group of GPs. However, our findings are
consistent with those of other similar studies, suggesting
that our methods detected known patterns of care. An-
other limitation is the relatively small sample of patients.
The study population consisted of individuals living with
combinations of specific chronic conditions. Recruiting a
broader range of patients with other chronic conditions
than the selected could have resulted in more differenti-
ating categories in the focus groups. Further, the study
group was selected from Bispebjerg University Hospital.
The population in the catchment area of Bispebjerg Uni-
versity Hospital is characterized by having lower educa-
tional attainment, a high number of people without a
job and lower income than the average in the Capital
Region [22]. This could potentially influence the
generalization of the results. However, the study popula-
tion included both people with high- and low educa-
tional attainment and as the results showed no
difference in the quality of care received by patients
from different socio-economic groups, we do not believe
that this have impacted the results significantly. Three
focus groups meetings were held. Most of the clinicians
who participated in the focus groups differed at each
meeting and only one person participated in all three
meetings. However, having different participants at each
meeting could have impacted results e.g. other aspects
of how care was provided could have been raised. Add-
itionally, the reviewed medical records are from 2013.
Significant changes in the DHS since 2013 includes the
introduction of a Shared Medical Card, which allows
health care providers from the different health care sec-
tors to access information about patient medication and
vaccinations. Whether the Shared Medical Card will im-
prove prescribing has yet to be seen, as it needs to be
updated frequently to convey the correct medication list.
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However, we assume that lack of time to review and ac-
cess the appropriateness of the medication for people
with multimorbidity is still a problem impacting the
quality of the medical treatment negatively.
Conclusions
Our findings indicate that quality issues exist for people
in Denmark with multimorbidity that are similar to
those reported for other populations. Multiple strategies
are required to shift the focus of primary and secondary
care from a focus on single diseases to person-centered
care, facilitate the availability of patient information to
healthcare professionals across care sectors, and prevent
potential adverse drug events. Further research is needed
to explore methods to improve care for people with
multimorbidity.
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